Quantcast
Last updated on April 16, 2014 at 11:49 EDT

Latest International AIDS Vaccine Initiative Stories

2010-08-16 07:45:00

Black Treatment Advocates Network (BTAN) Focuses on Improving Care for Thousands of Black Americans in the U.S. WHITEHOUSE STATION, N.J. and LOS ANGELES, Calif., Aug. 16 /PRNewswire-USNewswire/ -- The Black AIDS Institute (The Institute), with support from Merck, announced the launch of the Black Treatment Advocates Network (BTAN). BTAN, the first collaborative Network of its kind, will train and mobilize a team of treatment advocates with a mission to link Black Americans with HIV into...

2010-08-11 11:39:00

ATLANTA, Aug. 11 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, announces that Chief Executive Officer Dr. Robert McNally and Chief Financial Officer Mark Reynolds will be presenting at the 2010 Southern California Investor Conference on Tuesday, August 17. The GeoVax presentation will take place at 3:00 pm at The Island Hotel in Newport Beach, California. Hosted by California...

2010-07-22 11:22:00

SMYRNA, Ga., July 22 /PRNewswire-FirstCall/ -- Dr. Harriet L. Robinson, Chief Scientific Officer at GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, discussed the Company's pursuit of a vaccine during a July 20 interview on HealthRadio.net, the leading online talk radio portal devoted to health and medical issues. Dr. Robinson told her interviewer, Dr. Derrick DeSilva, that medical science is further ahead...

2010-07-20 06:49:00

VIENNA, July 20 /PRNewswire-USNewswire/ -- Following significant advances in vaccine and microbicide research, including results presented today of 39% efficacy in the CAPRISA 004 microbicide gel trial among women in South Africa, a new report released today warns that flat funding for HIV prevention research may limit researchers' ability to quickly move promising approaches forward. The report examines investment in HIV prevention research in 2009 and finds that the onset of a global...

2010-07-19 06:00:00

In Keynote Speech to AIDS Conference, Gates Outlines Roadmap to Reduce Annual New HIV Infections 90% by 2031 VIENNA, July 19 /PRNewswire-USNewswire/ -- Speaking to the 18th International AIDS Conference today, Bill Gates called on all countries to keep up the fight against HIV/AIDS, saying the world has an historic opportunity to "change the face of AIDS." Mr. Gates said current efforts to treat people with HIV are saving millions of lives, and urged a renewed focus on reducing annual...

2010-07-02 13:47:00

SMYRNA, Ga., July 2 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, is mentioned in two recent articles covering a historic HIV vaccine trial currently being conducted by the AIDS Research Consortium of Atlanta (ARCA) using a vaccine supplied by GeoVax. The first article, titled "ARCA Seeks Volunteers For Historic HIV Vaccine Trial," appeared in the June 11 print and online...

2010-06-02 13:43:02

The findings advance the effort to develop an AIDS vaccine In findings that contribute to efforts to design an AIDS vaccine, a team led by Scripps Research Institute scientists has determined the structure of an immune system antibody molecule that effectively acts against most strains of human immunodeficiency virus (HIV), the virus that causes AIDS. The study, which is being published in an advance, online issue of the journal Proceedings of the National Academy of Sciences (PNAS) during...

2010-05-27 11:07:00

ATLANTA, May 27 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, announced today The AIDS Research Consortium of Atlanta (ARCA) has received approval to begin enrollment of the first therapeutic trial ever conducted using a promising HIV vaccine candidate from GeoVax, Inc. Although the GeoVax vaccines are currently being studied for HIV prevention, this is the first study using the...

2010-05-20 07:00:00

SMYRNA, Ga., May 20 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVXD), a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, is spotlighted on an interactive map posted on the website of Inc. magazine. The map, created by Nitasha Tiku and April Joyner, is headlined "Incubation Nation: Where Great Ideas Are Born." Tiku and Joyner write: "Spun out of university research labs or started by local entrepreneurs trying to supercharge...

2010-05-17 12:23:00

NEW YORK, May 17 /PRNewswire-USNewswire/ -- For more than a decade, researchers and advocates have marked HIV Vaccine Awareness Day with varying degrees of hope, cynicism and despair. This year, in large part because of the results of the Thai Prime-Boost vaccine study, there is greater cause for hope than ever before and a renewed sense of urgency to transform this hope into a reality. In September 2009, the world's largest AIDS vaccine trial to date showed the first evidence that an...